Biostar Pharmaceuticals (NASDAQ:BSPM) announced its earnings results on Wednesday, November 15th. The company reported ($0.50) earnings per share for the quarter, RTT News reports. During the same period in the previous year, the firm earned ($3.12) EPS.
Biostar Pharmaceuticals (BSPM) traded down $0.01 during mid-day trading on Friday, hitting $1.81. 23,660 shares of the stock traded hands, compared to its average volume of 78,094. Biostar Pharmaceuticals has a one year low of $1.18 and a one year high of $4.30. The firm has a market cap of $4.80, a PE ratio of 2.56 and a beta of 1.85.
COPYRIGHT VIOLATION WARNING: This news story was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://ledgergazette.com/2017/12/02/biostar-pharmaceuticals-inc-bspm-releases-quarterly-earnings-results.html.
About Biostar Pharmaceuticals
Biostar Pharmaceuticals, Inc (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co, Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China).
Receive News & Ratings for Biostar Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biostar Pharmaceuticals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.